CLINICAL EFFICACY OF CLOPIDOGREL COMBINED WITH ASPIRIN FOR ACUTE MYOCARDIAL INFARCTION AND ITS EFFECTS ON HS-CRP, NT-PROBNP, CTNI, ET AND MMP-9 LEVELS
Junling Zhou,Longwei Li,Hao Hu,Jiawei Wu,Hongwu Chen,Kefu Feng,Likun Ma
DOI: https://doi.org/10.19193/0393-6384_2019_5_365
2019-01-01
Acta medica mediterranea
Abstract:Objective: To investigate the clinical efficacy of a combination of clopidogrel and aspirin in the treatment of acute myocardial infarction (AMI) and its effects on prothrombin time (PT); platelet aggregation rate (PAR); activated partial thrombin time (APTT); and levels of N-terminal brain natriuretic peptide precursor (NT-proBNP), cardiac troponin (cTnI), matrix metalloproteinase 9 (MMP-9), hypersensitive C-reactive protein (hs-CRP) and endothelin (ET). Method: Patients with AMI (n = 160) who were admitted to the emergency department of our hospital were selected as study subjects and were randomly divided into a control group (n = 80) and an observation group (n = 80) using the random number table method. Patients in both groups were given routine treatment for AM!. In addition, the control group was given aspirin alone, while the observation group was treated with clopidogrel combined with aspirin. The therapeutic effects of both treatments were evaluated after two courses of treatment. Clinical effectiveness and degrees of vascular recanalization and re-occlusion were compared between the two groups. PT, PAR, APTT, NT-proBNP, cTnl, MMP-9, hs-CRP and ET were determined before and after treatment in both groups. Results: Treatment effectiveness was significantly higher in the observation group (9625%) than in the control group (82.50%, p<0.05). The re-occlusion rate in the observation group was significantly lower than that in the control group, and the difference was statistically significant. Although the degree of recanalization was higher in the observation group than in the control group, the difference was not statistically significant (p>0.05). APTT values were higher post-treatment than before treatment in both groups (p<0.05). However, there was no statistical difference between the ascending range values of the two groups (p>0.05). Moreover, there was no significant change in PT between the two groups (p>0.05). After treatment, PAR, NT-proBNP, cTnl, MMP-9, hs-CRP and ET levels in both groups were significantly lower than their corresponding pre-treatment values (p<0.05), hut the decreases were more significant in the observation group than in the control group (p<0.05). Conclusion: Compared with aspirin alone, clopidogrel combined with aspirin offers better protection for patients with acute myocardial infarction, reduces clinical symptoms, enhances the clinical effect of treatment, and reduces the degree of re-occlusion. It reduces hs-CRP, MMP-9, ET and NT-pmBNP levels, delays atherosclerosis, and reduces the risk of bleeding in patients. Thus, the combination treatment merits clinical application.